Effect of fluvastatin on apoptosis in human CD4+ T cells

Statins are lipid-lowering agents with pleiotropic effects. We investigated the apoptotic effects of fluvastatin on peripheral CD4(+) T cells from healthy subjects. Fluvastatin induced apoptosis in resting CD4(+) T cells but not in CD4(+) T cells strongly activated with a high concentration of PMA plus ionomycin (PMA/I) analyzed with annexin V and propidium iodide staining. However, CD4(+) T cells activated with a low concentration of PMA/I or with anti-CD3 antibodies were apoptotic after treatment with fluvastatin. Activities of caspases-8, -9, and -3 were increased in resting CD4(+) T cells treated with fluvastatin (10 mu M). In strongly activated CD4(+) T cells, fluvastatin inhibited the activation of caspase-8 induced by PMA/I and increased caspase-9 activity. The caspase-3 activity did not differ between untreated and fluvastatin-treated strongly activated CD4(+) T cells. Treatment with fluvastatin (10 mu M) enhanced cytochrome c release and increased the Bax/Bcl-2 ratio in both resting and strongly activated CD4(+) T cells. Although the in vitro concentration of fluvastatin used in this study is higher than in vivo, other factors may sensitize apoptotic cell death of CD4(+) T cells in vivo. In conclusion, fluvastatin induces apoptosis in resting T cells but not in strongly activated T cells, a difference that might be due to the interaction between caspase-8 and caspase-9. (c) 2005 Elsevier Inc. All rights reserved.